DNMT3A and heart failure: We found that the expression of both HBEGF and AREG was significantly higher in circulating monocytes of heart failure patients carrying DNMT3A CHIP-driver mutations compared to No-CHIP carriers (Fig. 6h, Supplementary Fig. 7a).